Variant report
Variant | rs2914636 |
---|---|
Chromosome Location | chr19:21541342-21541343 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | MXI1 | chr19:21541166-21542571 | SK-N-SH | brain: | n/a | n/a |
2 | RFX5 | chr19:21541215-21542511 | SK-N-SH | brain: | n/a | chr19:21541703-21541712 |
3 | REST | chr19:21541197-21542532 | H1-neurons | neurons: | n/a | chr19:21541726-21541735 |
4 | NFYB | chr19:21541252-21542135 | GM12878 | blood: | n/a | chr19:21541729-21541742 chr19:21541700-21541714 chr19:21541726-21541741 chr19:21541697-21541712 chr19:21541700-21541715 chr19:21541702-21541712 chr19:21541700-21541715 chr19:21541700-21541713 |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZNF738 | TF binding region |
rs_ID | r2[population] |
---|---|
rs1012040 | 1.00[JPT][hapmap] |
rs10406824 | 1.00[JPT][hapmap] |
rs11085443 | 0.81[EUR][1000 genomes] |
rs11085455 | 1.00[JPT][hapmap] |
rs11671832 | 0.82[ASN][1000 genomes] |
rs12151067 | 0.83[AMR][1000 genomes];0.80[ASN][1000 genomes] |
rs12151068 | 0.83[AMR][1000 genomes];0.80[ASN][1000 genomes] |
rs12971724 | 0.80[AMR][1000 genomes];0.80[ASN][1000 genomes] |
rs12975981 | 0.86[CEU][hapmap];0.82[CHB][hapmap];1.00[JPT][hapmap];0.87[AMR][1000 genomes];0.85[ASN][1000 genomes] |
rs12981869 | 0.86[CEU][hapmap];0.82[CHB][hapmap];1.00[JPT][hapmap];0.87[AMR][1000 genomes];0.85[ASN][1000 genomes] |
rs12984238 | 0.80[AMR][1000 genomes];0.80[ASN][1000 genomes] |
rs1500400 | 1.00[JPT][hapmap] |
rs1500401 | 1.00[JPT][hapmap];0.94[YRI][hapmap] |
rs1520073 | 1.00[JPT][hapmap] |
rs1607664 | 1.00[JPT][hapmap] |
rs1678822 | 1.00[CEU][hapmap];0.85[CHB][hapmap];1.00[JPT][hapmap];0.83[AMR][1000 genomes];0.88[EUR][1000 genomes];0.82[ASN][1000 genomes] |
rs17618715 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[ASN][1000 genomes] |
rs17618778 | 0.87[CEU][hapmap];0.82[CHB][hapmap];1.00[JPT][hapmap];0.80[ASN][1000 genomes] |
rs1762580 | 0.82[AMR][1000 genomes];0.88[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs17680671 | 1.00[CHB][hapmap];0.89[ASN][1000 genomes] |
rs1813234 | 1.00[CEU][hapmap];0.93[YRI][hapmap];0.81[EUR][1000 genomes] |
rs1827225 | 0.86[ASN][1000 genomes] |
rs1984771 | 1.00[JPT][hapmap] |
rs2133816 | 1.00[JPT][hapmap] |
rs2133820 | 1.00[JPT][hapmap] |
rs2173724 | 1.00[JPT][hapmap] |
rs2246914 | 1.00[JPT][hapmap] |
rs2358984 | 1.00[CEU][hapmap];0.94[YRI][hapmap];0.85[AFR][1000 genomes];0.84[EUR][1000 genomes] |
rs2562399 | 1.00[JPT][hapmap] |
rs2562448 | 1.00[JPT][hapmap] |
rs2562457 | 1.00[JPT][hapmap] |
rs2562458 | 1.00[JPT][hapmap] |
rs2650779 | 1.00[JPT][hapmap] |
rs2650780 | 1.00[JPT][hapmap] |
rs2650781 | 1.00[JPT][hapmap] |
rs2650783 | 1.00[JPT][hapmap] |
rs2650791 | 1.00[JPT][hapmap] |
rs2650794 | 1.00[JPT][hapmap];0.94[YRI][hapmap] |
rs2650799 | 1.00[JPT][hapmap] |
rs2650845 | 0.86[CEU][hapmap] |
rs2681371 | 1.00[JPT][hapmap];0.82[YRI][hapmap] |
rs2681372 | 1.00[JPT][hapmap] |
rs28839521 | 0.83[AMR][1000 genomes];0.80[ASN][1000 genomes] |
rs2914637 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2928208 | 0.81[EUR][1000 genomes] |
rs2928210 | 0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs34560125 | 0.83[AMR][1000 genomes];0.80[ASN][1000 genomes] |
rs34875588 | 0.85[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs35148123 | 0.80[ASN][1000 genomes] |
rs35578515 | 0.87[AMR][1000 genomes];0.85[ASN][1000 genomes] |
rs35860067 | 0.83[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs4341872 | 0.87[CEU][hapmap] |
rs483383 | 0.82[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs488125 | 1.00[CEU][hapmap];0.88[EUR][1000 genomes] |
rs501647 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.90[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs504280 | 0.95[CEU][hapmap];0.88[EUR][1000 genomes] |
rs509540 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.83[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs514390 | 0.97[AMR][1000 genomes];0.92[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs531283 | 0.80[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs549882 | 0.98[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs552039 | 0.87[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs565406 | 0.83[EUR][1000 genomes] |
rs566230 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.83[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs57055133 | 1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs58121117 | 1.00[ASN][1000 genomes] |
rs59617671 | 1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs608002 | 0.97[AMR][1000 genomes];0.96[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs617186 | 0.87[EUR][1000 genomes] |
rs62107470 | 0.90[AMR][1000 genomes];0.91[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62107538 | 1.00[ASN][1000 genomes] |
rs62109224 | 1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs62110379 | 0.87[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs629548 | 0.90[CEU][hapmap];0.82[CHB][hapmap];1.00[JPT][hapmap] |
rs635730 | 0.82[AMR][1000 genomes];0.85[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs6511228 | 0.85[AFR][1000 genomes];0.84[EUR][1000 genomes] |
rs669046 | 0.91[CEU][hapmap];0.85[CHB][hapmap];1.00[JPT][hapmap] |
rs670813 | 0.87[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs67723811 | 0.80[ASN][1000 genomes] |
rs685844 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.83[AMR][1000 genomes];0.90[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7245848 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7246684 | 0.87[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs7248700 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.98[ASN][1000 genomes] |
rs7249636 | 1.00[CEU][hapmap] |
rs7252873 | 0.85[AFR][1000 genomes];0.84[EUR][1000 genomes] |
rs7254436 | 1.00[CHB][hapmap] |
rs7254762 | 1.00[CHB][hapmap];0.89[ASN][1000 genomes] |
rs7258086 | 0.85[AFR][1000 genomes];0.84[EUR][1000 genomes] |
rs73025767 | 1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs8099863 | 0.93[AMR][1000 genomes];0.98[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs8100318 | 1.00[JPT][hapmap] |
rs8102328 | 0.85[AFR][1000 genomes];0.84[EUR][1000 genomes] |
rs8102854 | 1.00[JPT][hapmap] |
rs8103411 | 0.85[ASN][1000 genomes] |
rs8103417 | 0.93[AMR][1000 genomes];0.99[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs8105404 | 0.87[AMR][1000 genomes];1.00[ASN][1000 genomes] |
rs8105629 | 0.87[CEU][hapmap];0.82[CHB][hapmap];1.00[JPT][hapmap] |
rs8107999 | 0.82[CHB][hapmap] |
rs8110470 | 0.83[AMR][1000 genomes];0.87[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs8111189 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[AMR][1000 genomes];0.97[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs8113558 | 0.87[CEU][hapmap];0.82[CHB][hapmap];1.00[JPT][hapmap];0.83[AMR][1000 genomes];0.85[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | esv3518033 | chr19:21278465-21747567 | Strong transcription Weak transcription ZNF genes & repeats Active TSS Enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 41 gene(s) | inside rSNPs | diseases |
2 | esv3518034 | chr19:21278465-21747567 | ZNF genes & repeats Weak transcription Genic enhancers Active TSS Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 41 gene(s) | inside rSNPs | diseases |
3 | esv3414204 | chr19:21301761-21839451 | ZNF genes & repeats Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Strong transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 44 gene(s) | inside rSNPs | diseases |
4 | nsv911416 | chr19:21388995-21548211 | Flanking Active TSS Weak transcription Strong transcription ZNF genes & repeats Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
5 | nsv911417 | chr19:21388995-21564001 | Weak transcription Strong transcription Active TSS ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
6 | esv3325271 | chr19:21445407-21792817 | Weak transcription ZNF genes & repeats Active TSS Flanking Active TSS Strong transcription Genic enhancers Enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
7 | nsv911420 | chr19:21454672-21613397 | ZNF genes & repeats Strong transcription Active TSS Weak transcription Enhancers Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 15 gene(s) | inside rSNPs | diseases |
8 | esv2751783 | chr19:21465822-21726337 | Strong transcription ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
9 | esv3363678 | chr19:21483148-21756908 | Strong transcription Active TSS ZNF genes & repeats Weak transcription Flanking Active TSS Genic enhancers Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 31 gene(s) | inside rSNPs | diseases |
10 | nsv963023 | chr19:21491992-21570395 | Weak transcription ZNF genes & repeats Enhancers Flanking Active TSS Strong transcription Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
11 | nsv578952 | chr19:21535707-21868584 | Genic enhancers Active TSS ZNF genes & repeats Enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs2914636 | ZNF493 | Cis_1M | lymphoblastoid | RTeQTL |
rs2914636 | CTD-2561J22.5 | cis | Esophagus Muscularis | GTEx |
rs2914636 | CTD-2561J22.5 | cis | Thyroid | GTEx |
rs2914636 | ZNF738 | cis | Thyroid | GTEx |
rs2914636 | ZNF493 | cis | Lymphoblastoid | GTEx |
rs2914636 | ZNF738 | Cis_1M | lymphoblastoid | RTeQTL |
rs2914636 | ZNF738 | cis | Adipose Subcutaneous | GTEx |
rs2914636 | ZNF493 | cis | multi-tissue | Pritchard |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:21536200-21541400 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |
2 | chr19:21536200-21541400 | Weak transcription | Primary T helper cells fromperipheralblood | blood |
3 | chr19:21541000-21541400 | Weak transcription | Brain Cingulate Gyrus | brain |
4 | chr19:21541200-21541400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr19:21541200-21541400 | Enhancers | Primary B cells from cord blood | blood |
6 | chr19:21541200-21541400 | Enhancers | Dnd41 | blood |
7 | chr19:21541200-21541400 | Enhancers | Osteobl | bone |
8 | chr19:21541200-21541600 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
9 | chr19:21541200-21541600 | Enhancers | Fetal Stomach | stomach |
10 | chr19:21541200-21543000 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |